FindTrial
Sign In

Discovery of biomarkers in the diagnosis and treatment of colorectal cancer

Discovery of biomarkers in the diagnosis and treatment of colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020299
Enrollment
Unknown
Registered
2018-12-22
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Gold Standard:Histology diagnosis
Index test:levels&#32
of&#32
vitamin&#32
D&#32
metabolites,&#32
bile&#32
acids&#32
and&#32
exosomes&#32
in&#32
serum
&#32
the&#32
compositions&#32
gut&#32
microbiome

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Disease group inclusion criteria: human with enteritis, colorectal polyps or colorectal cancer. Healthy control group Selection criteria: healthy human with an age matched to the disease group, no history of cancer, good self-reported health.

Exclusion criteria

Exclusion criteria: Tobacco, alcohol and other substance abuse history; a clear diagnosis of type II diabetes mellitus; severe hypertension; hepatobiliary, gastrointestinal disorders.

Design outcomes

Primary

MeasureTime frame
Vitamin D;Gut microbiome;Bile acid;Exosomes;—

Countries

China

Contacts

Public ContactXueyan Zhou

Xuzhou Medical University

zxy851107@xzhmu.edu.cn+86 15105200571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026